The primary efficacy outcome was IgE-mediated allergy to any food assessed by double-blind, placebo-controlled food challenge; open food challenge; medical diagnosis; or parental report at the closest reported time point to age 3 years. The gene discussed is IGHE; the disease is allergic disease.